<DOC>
	<DOCNO>NCT02502162</DOCNO>
	<brief_summary>The investigator test treatment low-dose naltrexone ( LDN ) symptom relief complex regional pain syndrome ( CRPS ) . Study participant randomly assign receive either LDN placebo period several week . During period participant ask come several visit , include sensory testing , physical assessment , questionnaire .</brief_summary>
	<brief_title>Low-Dose Naltrexone Treatment Complex Regional Pain Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Somatoform Disorders</mesh_term>
	<mesh_term>Complex Regional Pain Syndromes</mesh_term>
	<mesh_term>Reflex Sympathetic Dystrophy</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Upper and/or low extremity CRPS On stable treatment 3 month CRPS least 1 year Meet Budapest criterion CRPS time study . Any known allergy naltrexone naloxone Use prescription opioid analgesic illegal opioid use Current plan pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>